Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study

BACKGROUND: Because of the overwhelming benefit of thrombectomy for highly selected trial patients with large vessel occlusion (LVO), some trial-ineligible patients are being treated in practice. OBJECTIVE: To determine the safety and efficacy of thrombectomy in DAWN/DEFUSE-3-ineligible patients. ME...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurosurgery
Autores principales: Siegler, James E, Messé, Steven R, Sucharew, Heidi, Kasner, Scott E, Mehta, Tapan, Arora, Niraj, Starosciak, Amy K, De Los Rios La Rosa, Felipe, Barnhill, Natasha R, Mistry, Akshitkumar M, Patel, Kishan, Assad, Salman, Tarboosh, Amjad, Dakay, Katarina, Salwi, Sanjana, Wagner, Jeff, Bennett, Alicia, Jagadeesan, Bharathi D, Streib, Christopher, Weber, Stewart A, Chitale, Rohan, Volpi, John J, Mayer, Stephan A, Yaghi, Shadi, Jayaraman, Mahesh, Khatri, Pooja, Mistry, Eva A
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Research—Human—Clinical Studies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204769/
https://ncbi.nlm.nih.gov/pubmed/31758197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyz485
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares